Royal Bank of Canada
BBNX

Royal Bank of Canada’s Beta Bionics BBNX Stock Holding History

Royal Bank of Canada’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35K Sell
3,548
-4,861
-58% -$71.9K ﹤0.01% 5665
2025
Q4 		$256K Sell
8,409
-67,366
-89% -$1.8M ﹤0.01% 4615
2025
Q3 		$1.51M Buy
75,775
+73,179
+2,819% +$1.29M ﹤0.01% 3636
2025
Q2 		$38K Sell
2,596
-2,133
-45% -$30.2K ﹤0.01% 6037
2025
Q1 		$58K Buy
+4,729
New +$88.2K ﹤0.01% 5516

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royal Bank of Canada's BBNX Position: Q1 2026 in Review

Royal Bank of Canada reduced its Beta Bionics (BBNX) stake by 58% in Q1 2026, selling an estimated $71.9K and leaving 3,548 shares worth $35K. The position accounts for ﹤0.01% of the portfolio, ranked #5665.

Royal Bank of Canada first reported a position in BBNX in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.51M in Q3 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Royal Bank of Canada held 3,548 shares of Beta Bionics worth $35K as of Q1 2026.
  • Royal Bank of Canada sold 4,861 Beta Bionics shares in Q1 2026, an estimated $71.9K.
  • Beta Bionics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5665 holding.
  • Royal Bank of Canada first reported a position in Beta Bionics in Q1 2025 and has held it in 5 quarters since.
  • Royal Bank of Canada's Beta Bionics position peaked at $1.51M in Q3 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.